Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 03, 2022 07:00 ET | Source: Arbor Biotechnologies, Inc.

Arbor Biotechnologies to Present at the Bank of America Global Healthcare Conference

CAMBRIDGE, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
May 02, 2022 16:32 ET | Source: Arbor Biotechnologies, Inc.

Arbor Biotechnologies Announces Presentations at 2022 Annual Meeting of the American Society of Gene & Cell Therapy

CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced upcoming...
February 22, 2022 07:00 ET | Source: Arbor Biotechnologies, Inc.

Arbor Biotechnologies Appoints Steven J. Favaloro as Chief Financial Officer

CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the...
February 08, 2022 07:00 ET | Source: Arbor Biotechnologies, Inc.

EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive License Agreement to Advance Ex Vivo Engineered Cell Therapy Programs

BEIJING and CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for...
January 10, 2022 07:00 ET | Source: Arbor Biotechnologies, Inc.

Arbor Biotechnologies to Present at the 40th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced its...
November 09, 2021 07:00 ET | Source: Arbor Biotechnologies, Inc.

Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next-Generation Precision Editing Therapeutics

The most extensive toolbox of proprietary genomic editors in the industry to enable development of curative, next-generation genetic medicines Co-founded by David Walt, Ph.D. and Feng Zhang, Ph.D. ...
August 24, 2021 07:00 ET | Source: Arbor Biotechnologies, Inc.

Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell Therapies

CAMBRIDGE, Mass., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Arbor Biotechnologies (Arbor) today announced a new collaboration to enhance efforts in...